We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

116 hedge funds and large institutions have $994M invested in Pacira BioSciences in 2013 Q2 according to their latest regulatory filings, with 116 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more call options, than puts

Call options by funds: $3.08M | Put options by funds: $2.44M

Holders
116
Holders Change
+116
Holders Change %
–
% of All Funds
3.79%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
116
Increased
–
Reduced
–
Closed
–
Calls
$3.08M
Puts
$2.44M
Net Calls
+$648K
Net Calls Change
+$648K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$8.93M +$8.9M +307,740 New
JP Morgan Chase
27
JP Morgan Chase
New York
$7.74M +$7.72M +266,799 New
TCM
28
Tygh Capital Management
Oregon
$7.54M +$7.52M +260,112 New
Allianz Asset Management
29
Allianz Asset Management
Germany
$7.12M +$7.1M +245,400 New
PC
30
Pier Capital
Connecticut
$6.79M +$6.77M +234,129 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$6.63M +$6.61M +228,636 New
BIA
32
Biondo Investment Advisors
Pennsylvania
$5.15M +$5.13M +177,490 New
UBS AM
33
UBS AM
Illinois
$4.65M +$4.64M +160,399 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$4.04M +$4.03M +139,282 New
CM
35
Castleark Management
Illinois
$3.74M +$3.73M +128,835 New
OAM
36
Oxford Asset Management
United Kingdom
$3.66M +$3.65M +126,122 New
Geode Capital Management
37
Geode Capital Management
Massachusetts
$3.29M +$3.28M +113,333 New
TCIM
38
TIAA CREF Investment Management
New York
$3.27M +$3.26M +112,657 New
SCA
39
SAC Capital Advisors
Connecticut
$3.21M +$3.2M +110,700 New
Wells Fargo
40
Wells Fargo
California
$3.09M +$3.08M +106,610 New
RJA
41
Raymond James & Associates
Florida
$2.83M +$2.82M +97,500 New
AP
42
AlpInvest Partners
Netherlands
$2.66M +$2.65M +91,700 New
TD Asset Management
43
TD Asset Management
Ontario, Canada
$2.36M +$2.35M +81,400 New
Neuberger Berman Group
44
Neuberger Berman Group
New York
$2.3M +$2.29M +79,250 New
KCM
45
Kingdon Capital Management
New York
$2.23M +$2.22M +76,784 New
BIM
46
BlackRock Investment Management
Delaware
$2.11M +$2.1M +72,765 New
EI
47
EAM Investors
California
$1.88M +$1.87M +64,641 New
Charles Schwab
48
Charles Schwab
California
$1.84M +$1.81M +62,511 New
RFC
49
Russell Frank Company
Washington
$1.63M +$1.63M +56,317 New
ARTA
50
A.R.T. Advisors
New York
$1.47M +$1.47M +50,729 New
1
2
3 4 5

PCRX Hedge Fund Activity: Q2 2013 in Review

116 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q2 2013, worth a combined $994M.

Buyers outnumbered sellers: 116 funds opened new PCRX positions and 0 closed out — a net gain of 116 holders — while 0 added to existing stakes and 0 trimmed.

  • 116 institutional investors held Pacira BioSciences (PCRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $994M of Pacira BioSciences stock for Q2 2013.
  • 116 funds opened new Pacira BioSciences positions in Q2 2013 and 0 closed out, a net change of +116 holders.

Based on aggregated 13F filings for Q2 2013.